KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Accumulated Depreciation & Amortization (2016 - 2025)

Idexx Laboratories has reported Accumulated Depreciation & Amortization over the past 17 years, most recently at $145.2 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 11.73% year-over-year to $145.2 million; the TTM value through Dec 2025 reached $145.2 million, up 11.73%, while the annual FY2025 figure was $145.2 million, 11.73% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $145.2 million at Idexx Laboratories, up from $129.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $145.2 million in Q4 2025 and troughed at $104.6 million in Q4 2021.
  • A 5-year average of $121.3 million and a median of $114.9 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 2.69% in 2023 and later rose 13.08% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $104.6 million in 2021, then increased by 6.98% to $111.9 million in 2022, then increased by 2.69% to $114.9 million in 2023, then grew by 13.08% to $129.9 million in 2024, then grew by 11.73% to $145.2 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for IDXX at $145.2 million in Q4 2025, $129.9 million in Q4 2024, and $114.9 million in Q4 2023.